Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Sandler

Showing results (51-60 of 321) with videos related to

Pageof 33
Sort By:
The Oncologist|January 25, 2013
The role of MET receptor tyrosine kinase in non-small cell lung cancer and clinical development of targeted anti-MET agentsKyle W Robinson, Alan B Sandler
Current Problems in Cancer|May 15, 1998
Treatment of advanced (stages III and IV) non-small-cell lung cancerC J Sweeney, A B Sandler
Lung|January 1, 1992
Lung cancer: a review of current therapeutic modalitiesA B Sandler, A C Buzaid
Lung Cancer (Amsterdam, Netherlands)|July 18, 2003
The importance of the eicosanoid pathway in lung cancerJanessa J Laskin, Alan B Sandler
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2006
Invisible barriers to clinical trials: the impact of structural, infrastructural, and procedural barriers to opening oncology clinical trialsDavid M Dilts, Alan B Sandler
Seminars in Oncology|June 5, 2004
COX-2 inhibition and lung cancerAlan B Sandler, Steven M Dubinett
Cancer Science|September 26, 2007
Inhibition of angiogenesis in the treatment of non-small cell lung cancerVicki L Keedy, Alan B Sandler
Cancer Treatment and Research|February 28, 2001
The epidemiology of lung cancerM D Williams, A B Sandler
Expert Opinion on Drug Safety|March 1, 2006
The safety of bevacizumabRachel E Sanborn, Alan B Sandler
Sovetskaia Meditsina|January 1, 1981
[Severe medicamentous disease induced by aminazine and barbiturates]B B Sandler, A D Shersneva
Pageof 33

Showing results (51-60 of 321) with videos related to

Sort By:
Pageof 33
The Oncologist|January 25, 2013
The role of MET receptor tyrosine kinase in non-small cell lung cancer and clinical development of targeted anti-MET agentsKyle W Robinson, Alan B Sandler
Current Problems in Cancer|May 15, 1998
Treatment of advanced (stages III and IV) non-small-cell lung cancerC J Sweeney, A B Sandler
Lung|January 1, 1992
Lung cancer: a review of current therapeutic modalitiesA B Sandler, A C Buzaid
Lung Cancer (Amsterdam, Netherlands)|July 18, 2003
The importance of the eicosanoid pathway in lung cancerJanessa J Laskin, Alan B Sandler
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2006
Invisible barriers to clinical trials: the impact of structural, infrastructural, and procedural barriers to opening oncology clinical trialsDavid M Dilts, Alan B Sandler
Seminars in Oncology|June 5, 2004
COX-2 inhibition and lung cancerAlan B Sandler, Steven M Dubinett
Cancer Science|September 26, 2007
Inhibition of angiogenesis in the treatment of non-small cell lung cancerVicki L Keedy, Alan B Sandler
Cancer Treatment and Research|February 28, 2001
The epidemiology of lung cancerM D Williams, A B Sandler
Expert Opinion on Drug Safety|March 1, 2006
The safety of bevacizumabRachel E Sanborn, Alan B Sandler
Sovetskaia Meditsina|January 1, 1981
[Severe medicamentous disease induced by aminazine and barbiturates]B B Sandler, A D Shersneva
Pageof 33